Skills/expertise
- Psychiatry, Psycho-oncology, Medical Database research
Education
- B.S. Computer Science and Information Engineering, National Taiwan University, Taipei, Taiwan.
- M.S. Computer Science and Information Engineering, National Taiwan University, Taipei, Taiwan.
- M.D. Department of Medicine, National Taiwan University, Taipei, Taiwan.
- Ph.D. Program, China Medical University, Taichung, Taiwan
Career
- 2006-2007 Resident, Department of Medicine, National Taiwan University Hospital, Taipei, Taiwan.
- 2007-2010 Resident, Department of Psychiatry, Buddhist Tzu-Chi General Hospital, Hualien, Taiwan.
- 2010-2011 Stanford Taiwan Biodesign Fellowship Program.
- 2011-2013 Chief resident and Fellow, Department of Psychiatry, China Medical University Hospital, Changhua, Taiwan.
- 2013- now Attending Physician, Sunshine Psychiatry Hospital, and Department of Psychiatry, China Medical University Hospital, Taichung, Taiwan.
Academic appointments
Honors
- Best Oral Presentation Award, and Best Poster Competition(Gold), the 5th Asia Pacific Psycho-Oncology Network Meeting & 3rd NUS Academic Psychiatry Conference, Singapore, 2016
- Student Encouragement Award, the 30th International College of Neuropsychopharmacology (CINP) World Congress of Neuropsychopharmacology, Korea, 2016
- Poster Award, the 7th Asia Pacific Regional Conference of the International Association for Suicide Prevention (IASP) jointly held with the 40th Japanese Association for Suicide Prevention (JASP) Tokyo, Japan, 2016
- Eli Lilly Scholarship, the European Society for Clinical and Economical Aspects of Osteoporosis (ESCEO)- Malaga, Spain, 2016
- Attending Physician Award, China Medical University Hospital, Taiwan, 2016
- Travel Grant, the 15th Congress of the International Federation for Psychiatric Epidemiology (IFPE) Bergen, Norway, 2015
- Oral Presentation Competition 3rd Place, the Taiwanese Osteoporosis Association Taiwan, 2015
- Evidence Based Medicine Competition 3rd Place, China Medical University Taiwan, 2013
- Outstanding Poster of 4th Asian Congress of Health Psychology (ACHP), Taiwan, 2010.
- Scholarship of Stanford Taiwan Bio-design Program, Taiwan, 2010.
Academic grant
2013-2014 Research Grant of China Medical University Hospital.
2015-2016 Research Grant of China Medical University Hospital.
Membership and professional societies
2007-current Member, Psychiatric Society of Republic of China.
Medical licensure and certification
2006 Medical license examination, Republic of China.
2013 Psychiatry Board Examination, Republic of China.
Publications on JCR-SCI journals:
1. Chang CH, Chen SY, Hsiao YL, Chen SJ, Tsai ST, Yeh YY, Tsai HC: Hypomania-like syndrome induced by deep brain stimulation of bilateral anterior limbs of the internal capsules. Prog Neuropsychopharmacol Biol Psychiatry. 2009; 33, 906-907.(SCI, IF=2.638)
2. Chang CH, Hsiao YL, Hsu CY, Chen ST: Treatment of Catatonia with Olanzapine : A Case Report. Prog Neuropsychopharmacol Biol Psychiatr.y 2009 Nov 13;33(8):1559-60 (SCI, IF=2.638)
3. Tsai HC, Chen SY, Tsai ST, Hung HY, Chang CH*(Corresponding author).: Hypomania following bilateral ventral capsule stimulation in a patient with refractory obsessive-compulsive disorder. Biol Psychiatry. 2010 Jul 15;68(2):e7-8. (SCI, IF=8.672)
4. Chang CH, Chen SY, Tsai ST, Hung HY, Tsai HC: Acute deep brain stimulation effects of bilateral anterior limbs of the internal capsules in obsessive-compulsive disorder. International Journal of Neuropsychopharmacology, supplement issue, abstracts of CINP. 2010 Jun p198. (SCI, IF=4.378)
5. Chang CH, Chen SY, Hsiao YL, Tsai ST, Tsai HC: Hypomania with hypersexuality following bilateral anterior limbs stimulation in obsessive-compulsive disorder. Journal of Neurosurgery. 2010 Jun;112(6):1299-300. (SCI, IF= 2.124)
6. Chang CH, Chen SJ, Chang CH, Tsai HC: Manic episode following a combined treatment of repetitive transcranial magnetic stimulation and venlafaxine. J Neuropsychiatry Clin Neurosci. 2010 Spring;22(2):E18-9. (SCI, IF=2.362)
7. Chang CH, Tsai HC: Reply to: Are the anterior internal capsules and nucleus accumbens suitable DBS targets for the treatment of depression? Prog Neuropsychopharmacol Biol Psychiatry. 2011 Jan 15;35(1):310. (SCI, IF=2.638)
8. Hsiao YL, Chen SJ, Hsu CY, Chang CH, Chen ST: Aripiprazole augmentation induced hypertension in major depressive disorder: a case report. Prog Neuropsychopharmacol Biol Psychiatry. 2011 Jan 15;35(1):305-6. (SCI, IF=2.638)
9. Tsai HC, Chang CH, Pan JI, Hsieh HJ, Tsai ST, Hung HY, Chen SY: Pilot study of deep brain stimulation in refractory obsessive-compulsive disorder ethnic Chinese patients. Psychiatry Clin Neurosci. 2012 Jun;66(4):303-12. (SCI, IF=2.04)
10. Chen SJ, Chang CH, Tsai HC, Chen ST, Lin CCh: Superior antidepressant effect occurring 1 month after rTMS: add-on rTMS for subjects with medication-resistant depression. Neuropsychiatr Dis Treat. 2013;9:397-401. (SCI, IF=2)
11. Tsai HC, Chang CH, Pan JI, Hsieh HJ, Tsai ST, Hung HY, Chen SY: acute stimulation effect of the ventral capsule/ventral striatum in patients with refractory obsessive–compulsive disorder – a double-blinded trial. Neuropsychiatr Dis Treat 2014:10 63–69. (SCI, IF=2)
12. Wei CC, Chang CH, Lin CL, Chang SN, Li TC, Kao CH. Neonatal Jaundice and Increased Risk of Attention-Deficit Hyperactivity Disorder: A Population-Based Cohort Study, J Child Psychol Psychiatry. 2015 Apr; 56(4):460-7. (SCI=5.422)
13. Chang CH, Chen SJ, Liu CY. Adjuvant treatments of breast cancer increase the risk of depressive disorders: A population-based study. J Affect Disord. 2015 Apr 23;182:44-49.
14. Chang CH, Chen SJ, Liu CY. Fracture risk and adjuvant therapies in young breast cancer patients: A population-based study. PLoS One. 2015 Jun 24;10(6):e0130725.
15. Chang CH, Chen SJ, Liu CY. Risk of Developing Depressive Disorders following Hepatocellular Carcinoma: A Nationwide Population-Based Study. PLoS One. 2015 Aug 21;10(8):e0135417.
16. Chen SJ, Chang CH, Liu CY. Association Between Depressive disorders and Risk of Breast Cancer Recurrence Following Curative Surgery. Medicine 2016 Aug;95(33):e4547.
17. Chang CH, Chen SJ, Liu CY, Lane HY.: A reduced risk of severe hepatic outcome with paliperidone exposure in schizophrenia patients with viral hepatitis: a population-based retrospective cohort study. International Journal of Neuropsychopharmacology, supplement issue, abstracts of CINP. 2016 June p187. (SCI, IF=4.333)
Patents
1. United States Provisional Patent 61471700, 2011
2. United States Provisional Patent 61489978, 2011
Q: 看診時間甚麼時候?
